The effects of astaxanthin supplementation on expression of microRNAs involved in cardiovascular diseases: a systematic review of current evidence

References

• Ali Sheikh MS. 2020. Overexpression of miR-375 protects cardiomyocyte injury following hypoxic-reoxygenation injury. Oxid Med Cell Longevity. 2020:1–10.
   Web of Science ®Google Scholar
• Ambati RR, Moi PS, Ravi S, Aswathanarayana RG. 2014. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications - a review. Mar Drugs. 12(1):128–152.
   PubMed Web of Science ®Google Scholar
• Aquila G, Marracino L, Martino V, Calabria D, Campo G, Caliceti C, Rizzo P. 2019. The use of nutraceuticals to counteract atherosclerosis: the role of the notch pathway. Oxid Med Cell Longev. 2019:5470470–5470470.
   PubMed Web of Science ®Google Scholar
• Bae M, Kim MB, Lee JY. 2022. Astaxanthin attenuates the changes in the expression of microRNAs involved in the activation of hepatic stellate cells. Nutrients. 14(5):962.
   PubMed Web of Science ®Google Scholar
• Barwari T, Joshi A, Mayr M. 2016. MicroRNAs in cardiovascular disease. J Am Coll Cardiol. 68(23):2577–2584.
   PubMed Web of Science ®Google Scholar
• Burgos LM, Farina J, Liendro MC, Saldarriaga C, Liprandi AS, Wyss F, Mendoza I, Baranchuk A. 2020. Neglected tropical diseases and other infectious diseases affecting the heart. The NET-heart project: rationale and design. Global Heart. 15(1):1–5.
   PubMed Web of Science ®Google Scholar
• Çakmak HA, Demir M. 2020. MicroRNA and cardiovascular diseases. Balkan Med J. 37(2):60–71. eng.
   PubMed Web of Science ®Google Scholar
• Carbonell T, Gomes AV. 2020. MicroRNAs in the regulation of cellular redox status and its implications in myocardial ischemia-reperfusion injury. Redox Biol. 36(May):101607–101607.
   PubMedGoogle Scholar
• Cui G, Li L, Xu W, Wang M, Jiao D, Yao B, Xu K, Chen Y, Yang S, Long M, et al. 2020. Astaxanthin protects ochratoxin A-induced oxidative stress and apoptosis in the heart via the Nrf2 pathway. Oxid Med Cell Longev. 2020:7639109–7639109.
   PubMed Web of Science ®Google Scholar
• Dose J, Matsugo S, Yokokawa H, Koshida Y, Okazaki S, Seidel U, Eggersdorfer M, Rimbach G, Esatbeyoglu T. 2016. Free radical scavenging and cellular antioxidant properties of astaxanthin. IJMS. 17(1):103.
   Google Scholar
• Eisenreich A, Rauch U. 2011. PI3K inhibitors in cardiovascular disease. Cardiovasc Ther. 29(1):29–36.
   PubMed Web of Science ®Google Scholar
• Farkhondeh T, Folgado SL, Pourbagher-Shahri AM, Ashrafizadeh M, Samarghandian S. 2020. The therapeutic effect of resveratrol: focusing on the Nrf2 signaling pathway. Biomed Pharmacother. 127:110234–110234.
   PubMed Web of Science ®Google Scholar
• Gai YS, Ren YH, Gao Y, Liu HN. 2020. Astaxanthin protecting myocardial cells from hypoxia/reoxygenation injury by regulating miR-138/HIF-1α axis. Eur Rev Med Pharmacol Sci. 24(14):7722–7731.
   PubMed Web of Science ®Google Scholar
• Garikipati VNS, Verma SK, Jolardarashi D, Cheng Z, Ibetti J, Cimini M, Tang Y, Khan M, Yue Y, Benedict C, et al. 2017. Therapeutic inhibition of miR-375 attenuates post-myocardial infarction inflammatory response and left ventricular dysfunction via PDK-1-AKT signalling axis. Cardiovasc Res. 113(8):938–949.
   PubMed Web of Science ®Google Scholar
• Hafez HA, Kamel MA, Osman MY, Osman HM, Elblehi SS, Mahmoud SA. 2021. Ameliorative effects of astaxanthin on brain tissues of Alzheimer’s disease-like model: cross talk between neuronal-specific microRNA-124 and related pathways. Mol Cell Biochem. 476(5):2233–2249.
   PubMed Web of Science ®Google Scholar
• Hooijmans CR, Rovers MM, de Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. 2014. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 14(1):43.
   PubMed Web of Science ®Google Scholar
• Howden R. 2013. Nrf2 and cardiovascular defense. Oxid Med Cell Longev. 2013:104308–104308. eng.
   PubMed Web of Science ®Google Scholar
• Kim HY, Kim YM, Hong S. 2019. Astaxanthin suppresses the metastasis of colon cancer by inhibiting the MYC-mediated downregulation of microRNA-29a-3p and microRNA-200a. Sci Rep. 9(1):1–10.
   PubMed Web of Science ®Google Scholar
• Kowshik J, Nivetha R, Ranjani S, Venkatesan P, Selvamuthukumar S, Veeravarmal V, Nagini S. 2019. Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF-κΒ/STAT3 signalling axis in oral squamous cell carcinoma models. IUBMB Life. 71(10):1595–1610.
   PubMed Web of Science ®Google Scholar
• Lee Y, Gustafsson AB. 2009. Role of apoptosis in cardiovascular disease. Apoptosis. 14(4):536–548. eng.
   PubMed Web of Science ®Google Scholar
• Leopold JA, Loscalzo J. 2009. Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med. 47(12):1673–1706.
   PubMed Web of Science ®Google Scholar
• Li X, Qi Z, Zhao L, Yu Z. 2016. Astaxanthin reduces type 2 diabetic‑associated cognitive decline in rats via activation of PI3K/Akt and attenuation of oxidative stress. Mol Med Rep. 13(1):973–979.
   PubMed Web of Science ®Google Scholar
• Li L, Xu J, Yang D, Tan X, Wang H. 2010. Computational approaches for microRNA studies: a review. Mamm Genome. 21(1–2):1–12.
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Wang L, Han N, Yin G. 2021. miR-375-3p contributes to hypoxia-induced apoptosis by targeting forkhead box P1 (FOXP1) and Bcl2 like protein 2 (Bcl2l2) in rat cardiomyocyte h9c2 cells. Biotechnol Lett. 43(2):353–367.
   PubMed Web of Science ®Google Scholar
• Ma Z, Qi J, Meng S, Wen B, Zhang J. 2013. Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway. Eur J Appl Physiol. 113(10):2473–2486.
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 3(11):e442. eng.
   PubMed Web of Science ®Google Scholar
• McManus DD, Ambros V. 2011. Circulating microRNAs in cardiovascular disease. Circulation. 124(18):1908–1910.
   PubMed Web of Science ®Google Scholar
• Mellis D, Caporali A. 2018. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target. Biochem Soc Trans. 46:11–21.
   PubMed Web of Science ®Google Scholar
• Miki W. 1991. Biological functions and activities of animal carotenoids. Pure Appl Chem. 63(1):141–146.
   Web of Science ®Google Scholar
• Navickas R, Gal D, Laucevičius A, Taparauskaitė A, Zdanytė M, Holvoet P. 2016. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review. Cardiovasc Res. 111(4):322–337.
   PubMed Web of Science ®Google Scholar
• Ni X, Yu H, Wang S, Zhang C, Shen S. 2017. Astaxanthin inhibits PC-3 xenograft prostate tumor growth in nude mice. Mar Drugs. 15(3):66.
   Web of Science ®Google Scholar
• Niture SK, Jaiswal AK. 2012. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem. 287(13):9873–9886. eng.
   PubMed Web of Science ®Google Scholar
• O'Brien J, Hayder H, Zayed Y, Peng C. 2018. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 9(AUG):402–412.
   PubMedGoogle Scholar
• Ono K, Kuwabara Y, Han J. 2011. MicroRNAs and cardiovascular diseases. Febs J. 278(10):1619–1633.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71.
   PubMed Web of Science ®Google Scholar
• Parga C, Pereira M, Carolina ANA, Souza R, Vasconcelos AR, Prado PS, Name JJ. 2020. Antioxidant and anti ‑ inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review). Int J Mol Med. 47(1):37–48.
   PubMed Web of Science ®Google Scholar
• Romaine SP, Tomaszewski M, Condorelli G, Samani NJ. 2015. MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart. 101(12):921–928. eng.
   PubMed Web of Science ®Google Scholar
• Salas-Huetos A, James ER, Aston KI, Carrell DT, Jenkins TG, Yeste M. 2020. The role of miRNAs in male human reproduction: a systematic review. Andrology. 8(1):7–26.
   PubMed Web of Science ®Google Scholar
• Satta S, Mahmoud AM, Wilkinson FL, Yvonne Alexander M, White SJ. 2017. The role of Nrf2 in cardiovascular function and disease. Oxid Med Cell Longev. 2017:9237263–9237263.
   PubMed Web of Science ®Google Scholar
• Schüttler D, Clauss S, Weckbach LT, Brunner S. 2019. Molecular mechanisms of cardiac remodeling and regeneration in physical exercise. Cells. 8(10):1128.
   Web of Science ®Google Scholar
• Senoner T, Dichtl W. 2019. Oxidative stress in cardiovascular diseases: still a therapeutic target? Nutrients. 11(9):2090.
   PubMed Web of Science ®Google Scholar
• Shatoor AS, Al Humayed S, Almohiy HM. 2022. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2. J Physiol Biochem. 78(1):151–168. eng.
   PubMed Web of Science ®Google Scholar
• Shen DF, Qi HP, Ma C, Chang MX, Zhang WN, Song RR. 2021. Astaxanthin suppresses endoplasmic reticulum stress and protects against neuron damage in Parkinson’s disease by regulating miR-7/SNCA axis. Neurosci Res. 165:51–60. eng.
   PubMed Web of Science ®Google Scholar
• Shokri-Mashhadi N, Tahmasebi M, Mohammadi-asl J, Zakerkish M, Mohammadshahi M. 2021. The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled clinical trial. Int J Clin Pract. 75(5):e14022.
   PubMed Web of Science ®Google Scholar
• Shu K, Zhang Y. 2019. Protodioscin protects PC12 cells against oxygen and glucose deprivation-induced injury through miR-124/AKT/Nrf2 pathway. Cell Stress Chaperones. 24(6):1091–1099.
   PubMed Web of Science ®Google Scholar
• Siragusa M, Katare R, Meloni M, Damilano F, Hirsch E, Emanueli C, Madeddu P. 2010. Involvement of phosphoinositide 3-kinase\&\#x3b3; in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res. 106(4):757–768.
   PubMed Web of Science ®Google Scholar
• Sztretye M, Dienes B, Gönczi M, Czirják T, Csernoch L, Dux L, Szentesi P, Keller-pintér A. 2019. Astaxanthin: a potential mitochondrial-targeted antioxidant treatment in diseases and with aging. Oxid Med Cell Longev. 2019:3849692.
   PubMed Web of Science ®Google Scholar
• Wang L, Song G, Liu M, Chen B, Chen Y, Shen Y, Zhu J, Zhou X. 2016. MicroRNA-375 overexpression influences P19 cell proliferation, apoptosis and differentiation through the Notch signaling pathway. Int J Mol Med. 37(1):47–55.
   PubMed Web of Science ®Google Scholar
• Xie WJ, Hou G, Wang L, Wang SS, Xiong XX. 2020. Astaxanthin suppresses lipopolysaccharide‑induced myocardial injury by regulating MAPK and PI3K/AKT/mTOR/GSK3$β$signaling. Mol Med Rep. 22(4):3338–3346.
   PubMed Web of Science ®Google Scholar
• Xu X, Li X. 2014. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci. 18:3091–3096.
   Google Scholar
• Zarneshan SN, Fakhri S, Farzaei MH, Khan H, Saso L. 2020. Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications. Food Chem Toxicol. 145:111714–111714.
   PubMed Web of Science ®Google Scholar
• Zhang H, Tian Y, Liang D, Fu Q, Jia L, Wu D, Zhu X. 2020. The effects of inhibition of microRNA-375 in a mouse model of doxorubicin-induced cardiac toxicity. Med Sci Monit. 26:e920557–e920557. eng.
   Web of Science ®Google Scholar
• Zhang J, Guo Y, ping Si J b, Sun X b, Sun G, jing Liu J. 2017. A polysaccharide of Dendrobium officinale ameliorates H2O2-induced apoptosis in H9c2 cardiomyocytes via PI3K/AKT and MAPK pathways. Int J Biol Macromol. 104(Pt A):1–10.
   PubMedGoogle Scholar
• Zhou S, Sun W, Zhang Z, Zheng Y. 2014. The role of Nrf2-mediated pathway in cardiac remodeling and heart failure. Oxid Med Cell Longev. 2014:260429–260429.
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang J, Li Y, Cui L, Wu K, Luo H. 2021. Astaxanthin inhibits microglia M1 activation against inflammatory injury triggered by lipopolysaccharide through down-regulating miR-31-5p. Life Sci. 267(January):118943.
   PubMedGoogle Scholar
• Zhu S, Wang T, Luo F, Li H, Jia Q, He T, Wu H, Zou T. 2019. Astaxanthin inhibits proliferation and induces apoptosis of LX‑2 cells by regulating the miR‑29b/Bcl‑2 pathway. Mol Med Rep. 19(5):3537–3547.
   PubMed Web of Science ®Google Scholar